[H-].[Al+3].[Li+].[H-].[H-].[H-].[CH2:7]([N:11]([CH2:49][CH:50]([CH3:52])[CH3:51])[C:12]([C:14]1[CH:48]=[CH:47][C:17]2[N:18]([CH2:34][CH2:35][CH2:36][N:37]([CH3:46])[CH2:38][CH2:39][C:40]3[CH:45]=[CH:44][CH:43]=[CH:42][N:41]=3)[C:19]([NH:21][C:22]3[CH:27]=[C:26]([O:28][CH3:29])[C:25]([O:30][CH3:31])=[C:24]([O:32][CH3:33])[CH:23]=3)=[N:20][C:16]=2[CH:15]=1)=O)[CH:8]([CH3:10])[CH3:9].C(OCC)(=O)C>O1CCCC1>[CH2:7]([N:11]([CH2:12][C:14]1[CH:48]=[CH:47][C:17]2[N:18]([CH2:34][CH2:35][CH2:36][N:37]([CH3:46])[CH2:38][CH2:39][C:40]3[CH:45]=[CH:44][CH:43]=[CH:42][N:41]=3)[C:19]([NH:21][C:22]3[CH:23]=[C:24]([O:32][CH3:33])[C:25]([O:30][CH3:31])=[C:26]([O:28][CH3:29])[CH:27]=3)=[N:20][C:16]=2[CH:15]=1)[CH2:49][CH:50]([CH3:51])[CH3:52])[CH:8]([CH3:10])[CH3:9]A molar solution of lithium aluminium hydride in tetrahydrofuran (0.83 ml, 5 eq) is added dropwise to a solution of N,N-diisobutyl-1-{3-[methyl(2-pyridin-2-ylethyl)amino]propyl}-2-[(3,4,5-trimethoxyphenyl)amino]-1H-benzimidazole-5-carboxamide (105 mg, 1 eq. prepared according to Example A1) cooled down to 0° C., in tetrahydrofuran (3 ml). After stirring for 15 minutes at 0° C., the mixture is heated at 60° C. for 3 hours then cooled down to 0° C. and hydrolysed. After adding ethyl acetate, decanting and extraction, the combined organic phases are washed with salt water, followed by drying over sodium sulphate and concentrating under reduced pressure. Purification by flash chromatography on silica gel (eluent: 100% dichloromethane to dichloromethane/methanol 9:1) produces the expected compound in the form of a foam (63 mg, 62% yield).